Morphine Enrolling by Invitation Phase 2 Trials for Pulmonary Arterial Hypertension (PAH) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03401476Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension